Literature DB >> 17013853

Development of sarcoidosis during etanercept therapy.

Marcos A González-López1, Ricardo Blanco, M Carmen González-Vela, Héctor Fernández-Llaca, Vicente Rodríguez-Valverde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17013853     DOI： 10.1002/art.22238

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  20 in total

1.  Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.

Authors:  Peter Korsten; Nadera J Sweiss; Ulf Nagorsnik; Timothy B Niewold; Hermann-Josef Gröne; Oliver Gross; Gerhard A Müller
Journal:  Am J Kidney Dis       Date:  2010-10-25       Impact factor: 8.860

Review 2.  Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature.

Authors:  Theoni Kanellopoulou; Anna Filiotou; Hariklia Kranidioti; Spyridon P Dourakis
Journal:  Clin Rheumatol       Date:  2010-10-23       Impact factor: 2.980

3.  Acute interstitial nephritis associated with etanercept.

Authors:  Toshiro Sugimoto; Mako Yasuda; Masayoshi Sakaguchi; Tetsuro Koyama; Takashi Uzu; Junichi Nishioka; Atsunori Kashiwagi
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

4.  Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.

Authors:  Tobias Lahmer; Andreas Knopf; Ines Lanzl; Uwe Heemann; Klaus Thuermel
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 5.  Pulmonary complications of tumor necrosis factor-targeted therapy.

Authors:  Krishna Thavarajah; Peggy Wu; Elisa J Rhew; Anjana K Yeldandi; David W Kamp
Journal:  Respir Med       Date:  2009-02-07       Impact factor: 3.415

6.  Update on bioagent therapy in sarcoidosis.

Authors:  Vincent Cottin
Journal:  F1000 Med Rep       Date:  2010-02-24

7.  Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis.

Authors:  S K Metyas; R M Tadros; D G Arkfeld
Journal:  Rheumatol Int       Date:  2008-09-02       Impact factor: 2.631

8.  Development of sarcoidosis following etanercept treatment: a report of three cases.

Authors:  Inger Marie Skoie; Klaus Wildhagen; Roald Omdal
Journal:  Rheumatol Int       Date:  2010-01-09       Impact factor: 2.631

9.  A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis.

Authors:  Gönen Mengi; Feride Göğüş
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

10.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.